Cite
MLA Citation
Thomas Mondritzki et al.. “Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure.” European journal of heart failure, vol. 23, 2021, pp. 743–750. http://access.bl.uk/ark:/81055/vdc_100133618708.0x000028